Ozanimod in relapsing forms of multiple sclerosis: a profile of its use

Authors
Category Primary study
JournalDrugs and Therapy Perspectives
Year 2021
This article has no abstract
Epistemonikos ID: c6063901155423cf435f17ddf87730c48004bfd6
First added on: Mar 31, 2022